Biomerica (BMRA) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$1.3 million.
- Biomerica's Net Income towards Common Stockholders fell 3894.74% to -$1.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$4.0 million, marking a year-over-year increase of 2822.48%. This contributed to the annual value of -$5.0 million for FY2025, which is 1684.51% up from last year.
- Latest data reveals that Biomerica reported Net Income towards Common Stockholders of -$1.3 million as of Q4 2025, which was down 3894.74% from $2000.0 recorded in Q3 2025.
- Over the past 5 years, Biomerica's Net Income towards Common Stockholders peaked at $2000.0 during Q3 2025, and registered a low of -$2.1 million during Q1 2021.
- In the last 5 years, Biomerica's Net Income towards Common Stockholders had a median value of -$1.5 million in 2023 and averaged -$1.4 million.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 148397.97% in 2023, then surged by 10015.2% in 2025.
- Over the past 5 years, Biomerica's Net Income towards Common Stockholders (Quarter) stood at -$1.1 million in 2021, then plummeted by 44.5% to -$1.6 million in 2022, then rose by 7.32% to -$1.5 million in 2023, then soared by 36.96% to -$950000.0 in 2024, then tumbled by 38.95% to -$1.3 million in 2025.
- Its last three reported values are -$1.3 million in Q4 2025, $2000.0 for Q3 2025, and -$1.5 million during Q2 2025.